DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,053 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,124,574 | +90.5% | 4,501 | +90.4% | 0.05% | +88.0% |
| Q1 2024 | $590,423 | +32.6% | 2,364 | +22.9% | 0.02% | +8.7% |
| Q4 2023 | $445,177 | +1.7% | 1,924 | +9.0% | 0.02% | -28.1% |
| Q3 2023 | $437,903 | -86.7% | 1,765 | -87.1% | 0.03% | -74.4% |
| Q2 2023 | $3,288,156 | -5.0% | 13,701 | -0.3% | 0.12% | -16.7% |
| Q1 2023 | $3,462,652 | +2.7% | 13,738 | +8.2% | 0.15% | -8.5% |
| Q4 2022 | $3,371,440 | +0.3% | 12,701 | -2.4% | 0.16% | -12.3% |
| Q3 2022 | $3,362,000 | +4.7% | 13,016 | +2.8% | 0.19% | +2.2% |
| Q2 2022 | $3,211,000 | -4.4% | 12,666 | +10.6% | 0.18% | -3.7% |
| Q1 2022 | $3,360,000 | -9.9% | 11,456 | +1.1% | 0.19% | -9.5% |
| Q4 2021 | $3,728,000 | +16.6% | 11,332 | +7.9% | 0.21% | -3.2% |
| Q3 2021 | $3,198,000 | +13.4% | 10,504 | 0.0% | 0.22% | +8.0% |
| Q2 2021 | $2,819,000 | +34.1% | 10,504 | +12.5% | 0.20% | +8.1% |
| Q1 2021 | $2,102,000 | +24.9% | 9,340 | +23.3% | 0.19% | -1.6% |
| Q4 2020 | $1,683,000 | +4.9% | 7,578 | +1.7% | 0.19% | -12.5% |
| Q3 2020 | $1,605,000 | +33.3% | 7,453 | +9.4% | 0.22% | +16.1% |
| Q2 2020 | $1,204,000 | +33.5% | 6,811 | +4.5% | 0.19% | +5.7% |
| Q1 2020 | $902,000 | -0.4% | 6,520 | +4.0% | 0.18% | +19.7% |
| Q3 2019 | $906,000 | -3.5% | 6,271 | -4.5% | 0.15% | -8.7% |
| Q2 2019 | $939,000 | +37.9% | 6,567 | +27.3% | 0.16% | +33.1% |
| Q1 2019 | $681,000 | – | 5,157 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |